Physician profile
Stuart Fischer
NPI 1083656086
$7,574.58
in general payments reported to CMS, 2019-2025
39 companies · $858 in 2025
The $858 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,221 · 2020: $795 · 2021: $1,326 · 2022: $1,054 · 2023: $1,051 · 2024: $1,270 · 2025: $858.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,179.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,179.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,328.30 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,049.33 | 2019-2025 | Jardiance |
| Merck Sharp & Dohme LLC | $552.24 | 2021-2025 | Verquvo, Capvaxive, Steglatro |
| Amgen INC. | $550.68 | 2019-2025 | Repatha, Repatha |
| Janssen Pharmaceuticals, INC | $549.52 | 2019-2024 | Xarelto |
| Pfizer INC. | $528.21 | 2019-2025 | |
| Amarin Pharma, INC. | $271.84 | 2019-2021 | |
| Sanofi-Aventis U.S. LLC | $231.61 | 2019-2024 | |
| Boston Scientific Corporation | $209.87 | 2019-2025 | Watchman Flx, Lux-Dx Insertable Cardiac Monitor |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $199.11 | 2019-2025 | Lifevest |
| Atricure, INC. | $161.63 | 2019-2024 | |
| Abiomed | $157.41 | 2025 | |
| Irhythm Technologies, INC. | $155.38 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Scpharmaceuticals INC. | $142.59 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $141.52 | 2022-2024 | Camzyos |
Show all 39 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stuart Fischer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.